New research has suggested that individuals who suffer from both heart failure and type II diabetes may benefit from taking daily aspirin. The study reviewed medical records from more than 12,000 indi ...
News
Researchers at MRCCTU at UCL join a major research project launched to crack aspirin’s anti-cancer properties
Cancer Research UK launched an international study today, to answer the final questions before aspirin could be recommended to reduce cancer risk. Studies have estimated that widespread use of low-do ...
Add-Aspirin recruitment continues in India!
Add-Aspirin is now open at 11 centres in India:
- Tata Memorial Hospital, Mumbai
- Chennai Breast Centre
- Jehangir Clinical Development Centre, Pune
- Tata Medical Centre, Kolkata
- Meditrina Institute of Medical Sciences, Nashik
- Shatabdi Hospital, Nagpur
- Vikram & Fortis Hospital, Bengaluru
- Cancer Institute (WIA), Chennai
- Regional Cancer Centre, Trivandrum
- Meenakshi Mission Hospital, Madurai
- IndoAmerican Cancer Centre, Hyderabad
New study reports: “No benefit of Celecoxib in Breast Cancer Patients”
New study reports: “No benefit of Celecoxib in Breast Cancer Patients”A recent study looking at the use of the non-steroidal anti-inflammatory drug (NSAID), celecoxib, in participants who have had sur ...
Christmas & New Year Closure Dates 2017/2018
Please note the Randomisation phone line will be closed from 5pm on Friday 22nd December and will reopen at 9am on 2nd January 2018.
The last date for sending translational samples to biobanks will be 30th December 2017.
Wales Cancer Bank will re-open on Tuesday 2nd Jan 2018 and Tayside Tissue Bank will reopen on Wednesday 3rd Jan 2018.
News and Resources